Expectant Mothers Taking Risperdal May Have Children with Cardiac Birth Defects, Studies Suggest

Published on June 17, 2014 by Laurie Villanueva

Text-Size:A A A+

 

A growing number of women are now being prescribed antipsychotic medications during pregnancy, a new study suggests, which may raise questions about whether a drug named in Risperdal lawsuits, as well as several others, can have harmful effects on their unborn children. According to research published by the U.S. National Library of Medicine, National Institutes of Health, more and more expectant mothers have been treated with psychotropic medications over the past few years. The 2013 study found a 2.5-fold increase in the number of antipsychotic drug scripts written for symptoms associated with bipolar disorder, schizophrenia and even depression, among other things.

How Many Mothers Taking Risperdal Will Have Children with Birth Defects?

But just because this practice is on the rise, does that necessarily mean it’s safe? A study published in an August 2013 issue of the Journal of Clinical Psychopharmacology found an increased likelihood of children born to Risperdal users having cardiac malformations and other birth defects, compared to those born to expectant mothers not taking the drugs. Postnatal disorders were also more commonly found in babies born to women who took an antipsychotic drug during pregnancy. But for Risperdal users in particular, side effects on children may be especially harmful.  In addition to the rising number of lawsuits filed by men who allegedly developed Risperdal gynecomastia, a condition categorized by male breast development, a 2010 study also linked the medication’s use to heart-related birth defects. Researchers from the University of Copenhagen collected data from 1998 and 2007, and found 429 instances of adverse side effects in children under the age of 17, more than half of which had deformities and experienced severe withdrawal symptoms. Meanwhile, hundreds of Risperdal lawsuits have been filed in the Philadelphia Court of Common Pleas on behalf of men and young boys who claim to have developed gynecomastia complications. Recent court documents show at least 500 claims now filed in the Pennsylvania litigation against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc. According to plaintiffs, Risperdal gynecomastia complications may result in liposuction and mastectomy procedures to remove the excess breast tissue that may have developed as a result of the medication.

Pursue a Risperdal Lawsuit Today

If you or a loved one developed male breast growth, or gynecomastia, after taking Risperdal, call an attorney at our Firm today to find out whether you are eligible to file a claim against Johnson & Johnson. Contact us now at .